Associazione Di 5-Fluoro-Uracile in Infusione Continua E Radioterapia Nelle Neoplasie Vescicali

Chabner B. : Pharmacologic principles of cancer treatment. W.B. Saunders, Philadelphia 1982.

Lokich J.J. : Infusion chemotherapy for cancer. Current Concept Oncol., 6; 3–8 (1984).

Heidelberger C. , Greisbach L. , Montag B.J. : Studies in fluorinated pyrimidines: II. Effects of transplanted tumor. Cancer Res., 18; 305–317 (1958).

Vermund H. , Hodgett J. , Ansfield F.J. : Effects of combined radiation and chemotherapy on transplanted tumors in mice. Amer. J. Radiol., 85; 559–567 (1961).

Vietti J. , Eggerding F. , Valeriote F. : Combined effect of X-radiation and 5-FU on survival of transplanted leukemics cells. JNCI, 47; 865–870 (1971).

Byfield Je. , Frankel S.S. , Hornback C.L. : Phase I and pharmacological study of 72 hour infused and hyperfractionated cyclical radiation. Intern. J. Radiat. Oncol. Biol. Phys., 11; 791–800 (1985).

Nigro D.E. : Combined therapy for cancer of anal canal. A preliminary report. Dis. Colon-Rectum, 17; 354–356 (1974).

Sischy B. : The use of radiation therapy in the management of squamous cell carcinoma of the anus and marginally resectable adenocarcinoma of the rectum. Intern. J. Radiat. Oncol. Biol. Phys., 11; 1587–1593 (1985).

Commings B.J. : Combined modality therapy with 5-fluorouracil Mitomycin C and radiation therapy for squamous cell cancers. In: Rosenthal C.J. , Rotman M. (eds): Clinical applications of continous infusion chemotherapy and concomitant radiation therapy, p. 133–147. Plenum Press, New York 1986.

John M. : Feasibility of nonsurgical definitive management of anal canal carcinoma. Intern. J. Radiat. Oncol. Biol. Phys., 13; 299–303 (1987).

Gastrointestinal Tumor Study Group: Prolongation of the disease-free interval in surgically treated rectal carcinoma. N. Engl. J. Med., 23; 1465–1472 (1985).

Byfield J.R. : Infusional 5-FU and X-ray therapy for nonresectable esophageal cancer. Cancer, 45; 1465–1472 (1985).

Coia L.R. : Esophageal cancer: Is esophagectomy necessary? Oncology, 3; 101–110 (1989).

Keane T.J. : Concomitant radiation and chemotherapy for squamous cell carcinoma of esophagus. Intern. J. Radiat. Oncol. Biol. Phys., 10; 89 (1984).

Moertel C.G. : Therapy of locally unresectable pancreatic cancer: a randomized comparison of high dose radiation alone, moderate dose radiation plus 5-FU and high dose radiation plus 5-FU. Gastrointestinal Study Group. Cancer, 48; 1705–1710 (1981).

Gastrointestinal Tumor Study Group: Treatment of locally unresectable carcinoma of the pancreas. JNCI, 80; 751–755 (1988).

Thomas G. : Concurrent radiation Mitomycin C and 5-FU in poor prognosis carcinoma of cervix. Preliminary result of phase I, II study. Intern. J. Radiat. Oncol. Biol. Phys., 10; 1785–1790 (1984).

John M. : Preliminary results of concomitant radiotherapy and chemotherapy in advanced cervical carcinoma. Gynecol. Oncol., 28; 101–110 (1987).

Ludgate S.M. : Synchronous 5-Fluorouracil, Mitomycin C and radiation therapy in the treatment of locally advanced carcinoma of the cervix. Intern. J. Radiat. Oncol. Biol. Phys., 15; 893–899 (1988).

Rotman M. : Treatment of advanced bladder carcinoma with irradiation and concomitant 5-FTJ infusion. Cancer, 59; 710–714 (1987).

Deren T.L. , Wilson W.L. : Use of 5-FU in treatment of bladder carcinomas. J. Urol., 83; 390–393 (1960).

Glen J.F. : Chemotherapy of bladder carcinoma with 5-Fluorouracil. Cancer Chemother. Rep., 27; 67–69 (1963).

Rotman M. , Aziz H. : Bladder carcinoma. In: Perez-Brady: Principles and practice of radiation oncology. J.B. Lippincott Co, p. 847–862, Philadelphia 1987.

Russel K.J. : Combined 5-Fluorouracil and irradiation for transitional cell carcinoma of the urinary bladder. Intern. J. Radiat. Oncol. Biol. Phys., 19; 693–699 (1990).

Rotman M. : Concomitant continuous infusion chemotherapy and radiation. Cancer, 65; 823–835 (1990).

Lange C. , Rotman M. : Chemo-radiation therapy of bladder cancer. Intern. J. Radiat. Oncol. Biol. Phys., 19; 817–819 (1990).